TAE Technologies' most advanced field-reversed configuration device — achieving record-breaking plasma temperatures and stability in pursuit of hydrogen-boron fusion.
Copernicus is the latest and most advanced field-reversed configuration (FRC) device built by TAE Technologies (formerly Tri Alpha Energy), based in Foothill Ranch, California. Named after the Renaissance astronomer, Copernicus builds on the performance breakthroughs of its predecessor, Norman, and is designed to push FRC plasmas to the extreme temperatures needed for TAE's ultimate fuel of choice: proton-boron-11 (p-11B) fusion.[1]
TAE's approach centers on the beam-driven FRC, in which neutral beam injection provides both plasma heating and current drive to sustain a stable, long-lived FRC plasma. The predecessor machine, Norman, demonstrated FRC plasma temperatures above 75 million degrees Celsius (approximately 6.5 keV) with excellent stability and confinement, validating the company's core physics approach.[2]
Copernicus is designed to extend these results substantially, targeting plasma conditions relevant to the intermediate milestone of demonstrating fusion-relevant performance. The machine incorporates upgraded neutral beam systems, improved plasma-facing components, and advanced diagnostic suites to characterize FRC behavior at higher temperatures and densities.[1]
Proton-boron-11 fusion is the most challenging fuel cycle under serious commercial pursuit. The reaction produces three alpha particles and no primary neutrons, which would dramatically simplify reactor engineering by eliminating most neutron-induced material damage and radioactive waste. However, it requires ion temperatures exceeding 1 billion degrees Celsius (roughly 100 keV) and overcoming substantially higher radiation losses compared to D-T fusion. TAE's staged approach uses each generation of machine to close the gap incrementally.[2]
TAE Technologies has raised over $1.2 billion from investors including Google, Chevron, Sumitomo, and the late Paul Allen's Vulcan Inc. The company has also developed significant spin-off technology platforms in power management and particle beam therapy for cancer treatment, diversifying its revenue base while pursuing its fusion mission.[3]